Xcout IntelDynavax
Dynavax Technologies Corporation is a biopharmaceutical company developing and commercializing vaccines, including HEPLISAV-B, a hepatitis B vaccine for adults. It also develops CpG 1018, an immune-stimulatory adjuvant used in vaccine development and partnered programs.
Subscribe to see Dynavax’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Dynavax at a glance
Dynavax is a biopharmaceuticals company. Xcout tracks 13 named people at Dynavax, including Ryan Spencer (Chief Executive Officer).
Dynavax leadership
- Ryan SpencerChief Executive Officer
- David NovackPresident and Chief Operating Officer
- Kelly MacDonaldChief Financial Officer
- Andrew DavisChief Business Officer
- Donn CasaleChief Commercial Officer
- Jeff CoonChief Human Resources Officer
7 more named people on record for Dynavax, with roles, board committees and tenure — see the full roster →
Recent Dynavax news
Dynavax competitors
A few of Dynavax's closest competitors — see the full list of competitors and alternatives →
HilleVax, Inc. is a biopharmaceutical company headquartered in Boston, Massachusetts, established through a collaboration with Takeda and Frazier Healthcare Partners. The company focuses on developing and commercializing Takeda's norovirus vaccine candidate.
Acelyrin, Inc. is a clinical-stage biopharmaceutical company developing medicines for immune-mediated diseases. Its lead program, izokibep, is an interleukin-17A inhibitor intended to treat inflammatory conditions such as hidradenitis suppurativa and psoriatic arthritis.
Chimerix, Inc. is a biopharmaceutical company that develops medicines for oncology and other critical illnesses, serving US-based healthcare audiences and patients.
MinervaX is a privately held biotechnology company headquartered in Copenhagen, Denmark, pursuing the development of a novel maternal prophylactic vaccine for the prevention of Group B Streptococcus disease.
Cidara Therapeutics, Inc. is a biotechnology company focused on developing late-phase antiviral and immunotherapy agents, with operations based in San Diego, California and Rahway, New Jersey.
Achaogen Inc was a biopharmaceutical company headquartered in South San Francisco, California. The company focused on discovering, developing, and commercializing novel antibacterial treatments.
Get Dynavax's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Dynavax in Xcout Intel
- 13 named people with titles, LinkedIn and board committees
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access